Growth Metrics

Insulet (PODD) Cash & Equivalents Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -9.44%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 19.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -36.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 36.60%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 40.99%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.52%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -0.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.25%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn -8.19%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -8.19%
Dec 31, 2025 2.00%
Sep 30, 2025 1.61%
Jun 30, 2025 16.54%
Mar 31, 2025 21.83%
Dec 31, 2024 6.40%
Sep 30, 2024 1.76%
Jun 30, 2024 -1.33%
Mar 31, 2024 -2.91%
Dec 31, 2023 -8.10%
Sep 30, 2023 -6.48%
Jun 30, 2023 -5.38%
Mar 31, 2023 45.53%
Dec 31, 2022 46.70%
Sep 30, 2022 19.80%
Jun 30, 2022 80.81%
Mar 31, 2022 76.41%
Dec 31, 2021 90.84%
Sep 30, 2021 89.16%
Jun 30, 2021 84.42%
Mar 31, 2021 59.27%
Dec 31, 2020 49.30%
Sep 30, 2020 101.64%
Jun 30, 2020 119.68%
Mar 31, 2020 38.36%
Dec 31, 2019 15.93%
Sep 30, 2019 24.92%
Jun 30, 2019 16.58%
Mar 31, 2019 5.01%
Dec 31, 2018 -2.44%
Sep 30, 2018 -4.53%
Jun 30, 2018 -2.09%
Mar 31, 2018 11.74%
Dec 31, 2017 21.71%
Sep 30, 2017 -11.28%
Jun 30, 2017 -25.19%
Mar 31, 2017 -19.61%
Dec 31, 2016 -2.88%
Sep 30, 2016 11.86%
Jun 30, 2016 -20.56%
Mar 31, 2016 -8.98%
Dec 31, 2015 28.89%
Sep 30, 2015 31.86%
Jun 30, 2015 27.43%
Mar 31, 2015 20.60%
Dec 31, 2014 17.18%
Sep 30, 2014 12.13%
Jun 30, 2014 18.04%
Mar 31, 2014 11.89%
Dec 31, 2013 9.75%
Sep 30, 2013 13.99%
Jun 30, 2013 8.53%